Angel Pinto

Suggest Changes
  • Citations Per Year
Learn More
Background:Preclinical studies have shown that PTEN loss enhances sensitivity to mammalian target of Rapamycin (mTOR) inhibitors because of facilitated PI3K (phosphatidylinositol-3 kinase)/Akt(More)
  • 1